QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis 期刊论文 EMBO JOURNAL, 2019, 卷号: 38, 期号: 5 作者:  Zhao, Yu[1];  Ding, Liya[2];  Wane, Dejie[3];  Ye, Zhenqing[4];  He, Yundong[5] 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/24 EZH2  gain-of-function mutation  metastasis  non-methyltransferase activity  p53   Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-kappa B Activation and PD-L1 Expression 期刊论文 MOLECULAR CELL, 2019, 卷号: 73, 期号: 1, 页码: 22-+ 作者:  Jin, Xin[1];  Ding, Donglin[2];  Yan, Yuqian[3];  Li, Hui[4];  Wang, Bo[5] 收藏  |  浏览/下载：25/0  |  提交时间：2019/12/24 CDK4/6 inhibitor  CHD1  MAP3K7  NF-κB  PD-L1  RB  immunotherapy  phosphorylation  prostate cancer  radiotherapy   In vivo microdialysis with ultra performance liquid chromatography-mass spectrometry for analysis of tetramethylpyrazine and its interaction with borneol in rat brain and blood 期刊论文 BIOMEDICAL CHROMATOGRAPHY, 2018, 卷号: 32, 期号: 6 作者:  Liao, Weiguo[1];  Huang, Xiaojie[2];  Yin, Yongxin[3];  Liu, Bin[4];  Zhu, Runzhi[5] 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/24 borneol  microdialysis  pharmacokinetics  tetramethylpyrazine  UPLC-MS/MS   Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer 期刊论文 EMBO MOLECULAR MEDICINE, 2018, 卷号: 10, 期号: 4 作者:  Yan, Yuqian[1];  An, Jian[2];  Yang, Yinhui[3];  Wu, Di[4];  Bai, Yang[5] 收藏  |  浏览/下载：20/0  |  提交时间：2019/12/24 AKT phosphorylation  androgen receptor  HDAC3  prostate cancer  RGFP966   Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer 期刊论文 NUCLEIC ACIDS RESEARCH, 2018, 卷号: 46, 期号: 4, 页码: 1895-1911 作者:  He, Yundong[1];  Lu, Ji[2];  Ye, Zhenqing[3];  Hao, Siyuan[4];  Wang, Liewei[5] 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/24 PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer 期刊论文 CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 4, 页码: 834-846 作者:  Yang, Yinhui[1];  Bai, Yang[2];  He, Yundong[3];  Zhao, Yu[4];  Chen, Jiaxiang[5] 收藏  |  浏览/下载：23/0  |  提交时间：2019/12/24 JIB-04 induces cell apoptosis via activation of the p53/Bcl-2/caspase pathway in MHCC97H and HepG2 cells 期刊论文 ONCOLOGY REPORTS, 2018, 卷号: 40, 期号: 6, 页码: 3812-3820 作者:  Liao, Weiguo[1];  Liu, Jie[2];  Liu, Bin[3];  Huang, Xiaojie[4];  Yin, Yongxin[5] 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/24 JIB-04  p53  Bcl-2  caspase pathway  hepatic carcinoma  apoptosis   Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells 期刊论文 PROTEIN AND PEPTIDE LETTERS, 2017, 卷号: 24, 页码: 413-418 作者:  Liu, Bin[1];  Zhang, Miaomiao[2];  Liu, Shuna[4];  Ying, Jie[3];  Zhang, Jingjing[5] 收藏  |  浏览/下载：3/0  |  提交时间：2019/04/24 Diosmetin  HepG2  P53  apoptosis  flavonoids  ERK and JNK phosphorylation   Dihydromyricetin Reduces TGF-beta Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells 期刊论文 PROTEIN AND PEPTIDE LETTERS, 2017, 卷号: 24, 页码: 419-424 作者:  Huang, Xiaojie[1];  Lian, Tianming[1];  Guan, Xiaoqian[4,5];  Liu, Bin[1,6];  Hao, Siyuan[1] 收藏  |  浏览/下载：10/0  |  提交时间：2019/04/24 Dihydromyricetin  anti-cancer  proliferation  apoptosis  P53  hepatocellular carcinoma   Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 Cells 期刊论文 2017, 卷号: 24, 期号: 5, 页码: 413 作者:  Liu, Bin[1];  Zhang, Miaomiao[2];  Liu, Shuna[4];  Ying, Jie[3];  Zhang, Jingjing[5] 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/10